[1] Verdecchia P, Reboldi G, Angeli F. The 2020 international society of hypertension global hypertension practice guidelines - key messages and clinical considerations[J]. Eur J Intern Med, 2020, 82: 1-6. [2] 中国心血管健康与疾病报告编写组.《中国心血管健康与疾病报告2020》概述[J].中国心血管病研究, 2021, 19(7): 582-590. The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Key points of report on cardiovascular health and diseases in China 2020[J]. Chinese Journal of Cardiovascular Research, 2021, 19(7): 582-590. (in Chinese) [3] Song P, Zhang Y, Yu J, et al. Global prevalence of hypertension in children: A systematic review and Meta-analysis[J]. JAMA Pediatr, 2019, 173(12): 1154-1163. [4] Dong J, Dong H, Yan Y, et al. Prevalence of hypertension and hypertension phenotypes after three visits in Chinese urban children[J]. J Hypertens, 2022, 40(7): 1270-1277. [5] Azegami T, Uchida K, Tokumura M, et al. Blood pressure tracking from childhood to adulthood[J]. Front Pediatr, 2021, 9: 785356. [6] Chu C, Liao YY, He MJ, et al. Blood pressure trajectories from childhood to youth and arterial stiffness in adulthood: A 30-year longitudinal follow-up study[J]. Front Cardiovasc Med, 2022, 9: 894426. [7] Yang L, Magnussen CG, Yang L, et al. Elevated blood pressure in childhood or adolescence and cardiovascular outcomes in adulthood: A systematic review[J]. Hypertension, 2020, 75(4): 948-955. [8] 余婷, 关德凤, 张冬萍, 等.子痫前期与肠道菌群[J].国际妇产科学杂志, 2019, 46(2):169-172. Yu T, Guang DF, Zhang DP, et al. Preeclampsia and intestinal flora[J]. Int J Gynecol Obstet, 2019, 46(2): 169-172. (in Chinese) [9] 魏勇军, 李晓琪, 戢博阳, 等. 肠道菌群与宿主关系解析及肠道菌群调控/合成研究进展[J].中国科学:生命科学, 2022, 52(2): 249-265. Wei YJ, Li XQ, Mie BY, et al. Analysis of intestinal flora-host relationship and research progress in intestinal flora regulation and synthesis[J]. Sci China Life Sci, 2022, 52(2): 249-265. (in Chinese) [10] Dan X, Mushi Z, Baili W, et al. Differential analysis of hypertension-associated intestinal microbiota[J]. Int J Med Sci, 2019, 16(6): 872-881. [11] Palmu J,Salosensaari A,Havulinna AS, et al. Association between the gut microbiota and blood pressure in a population cohort of 6 953 individuals[J]. J Am Heart Assoc, 2020, 9(15): e016641. [12] Lu W, Wang Y, Fang Z, et al. Bifidobacterium longum CCFM752 prevented hypertension and aortic lesion, improved antioxidative ability, and regulated the gut microbiome in spontaneously hypertensiverats[J]. Food Funct, 2022, 13(11): 6373-6386. [13] Yan D, Sun Y, Zhou X, et al. Regulatory effect of gut microbes on bloodpressure[J]. Animal Model Exp Med, 2022, 5(6): 513-531. [14] 米杰, 王天有, 孟玲慧, 等. 中国儿童青少年血压参照标准的研究制定[J]. 中国循证儿科杂志, 2010, 5(1): 4-14. Mi J, Wang TY, Meng LH, et al. Development of blood pressure reference standards for Chinese children and adolescents[J]. Chin J Evid Based Pediatr, 2010, 5(1): 4-14. (in Chinese) [15] 王文.中国血压测量指南[J].中华临床医师杂志:电子版, 2011, 6(15): 1101-1115. Wang W.Guidelines for blood pressure measurement in China[J]. Chin J Hpertens, 2011, 6(15): 1101-1115.(in Chinese) [16] Robles-Vera I, Toral M, De La Visitación N, et al. The probiotic lactobacillus fermentum prevents dysbiosis and vascular oxidative stress in rats with hypertension induced by chronic nitric oxideblockade[J]. Mol Nutr Food Res, 2018, 62(19): e1800298. [17] Liu J, An N, Ma C, et al.Correlation analysis of intestinal flora with hypertension[J]. Exp Ther Med, 2018, 16(3): 2325-2330. [18] Khalesi S, Sun J, Buys N, et al. Effect of probiotics on blood pressure:A systematic review and Meta-analysis of randomized, controlled trials[J]. Hypertension, 2014, 64(4): 897-903. [19] Zhao TX, Zhang L, Zhou N, et al. Long-term use of probiotics for the management of office and ambulatory blood pressure: A systematic review and meta-analysis of randomized, controlledtrials[J]. Food Sci Nutr, 2022, 11(1): 101-113. [20] Barbara G,Barbaro MR, Fuschi D, et al. Inflammatory and microbiota-related regulation of the intestinal epithelial barrier[J]. Front Nutr, 2021, 8: 718356. [21] Muralitharan R, Marques FZ. Diet-related gut microbial metabolites and sensing inhypertension[J]. J Hum Hypertens, 2021, 35(2): 162-169. [22] Jiang S, Shui Y, Cui Y, et al. Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II-induced hypertension[J]. Redox Biol, 2021,46: 102115. [23] Vallianou NG, Geladari E, Kounatidis D. Microbiome and hypertension: Where are we now?[J]. J Cardiovasc Med (Hagerstown),2020, 21(2): 83-88. [24] Dinakis E, Nakai M, Gill P, et al. Association between the gut microbiome and their metabolites with human blood pressure variability[J]. Hypertension,2022, 79(8):1690-1701. |